#Omicron subvariant BA.2 will likely become dominant worldwide, according to WHO's regional emergency director. Dr Dorit Nitzan said BA.2 won't fade away. "The expected trajectory is that it will become the new dominant variant,” Nitzan said citing Denmark jpost.com/health-and-wel…
There are more mutations in the receptor-binding domain of BA.2 compared with BA.1, the original #OmicronVariant. The receptor binding domain— RBD—is a short fragment on the viral spike protein that binds to a specific receptor—ACE2—on a host's cell to gain entry.
A look at a model of a coronavirus spike receptor-binding domain (pink) bound to a human cell's ACE2 receptor (purple) news-medical.net/health/What-is…
Ohio judge reverses a court order that would have forced a hospital to give a Covid patient ivermectin. Siding w/ the hospital, judge says the hospital bears no duty to honor an ivermectin prescription. Jeffrey Smith, who's vax hesitant, is on a ventilator ohiocapitaljournal.com/2021/09/06/jud…
“This Court is not determining if ivermectin will ever be effective and useful as a treatment for COVID-19,” Judge Michael Oster said. “However, based upon the evidence, it has not been shown to be effective at this juncture."
Oster continued: "The studies that tend to give support to ivermectin have had inconsistent results, limitations to the studies, were open label studies, were of low quality or low certainty..."